Results
1 -
10 of
25
(Click
here to explore results)
- Synthetic Methods in Drug Discovery: Volume 2, Chapter 14 Asymmetric Methods and Their Use in the Pharmaceutical Industry. Peter D. Smith, Mark A. Graham, Rachel H. Munday, Craig S. Donald, Thomas M. McGuire, Robert E. Kyne Jr.
, 2016
, Volume 2
, Pages 139-262
- Pharmaceutical Salts and Co-crystals, Chapter 13 Limits of the Co-crystal Concept and Beyond. Gerard Coquerel
, 2012
, Pages 300-317
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 6 Influence of Aromatic Rings on ADME Properties of Drugs. Deepak Dalvie, Sajiv Nair, Ping Kang, Cho-Ming Loi
, 2010
, Pages 275-327
- Foreign Compound Metabolism in Mammals: Volume 6, Drug kinetics. D. E. Hathway, P. G. Welling
, 1981
, Volume 6
, Pages 1-63
- UHPLC in Life Sciences, Chapter 12 UHPLC-MS for Multi-residue Screening of Pharmaceuticals in Environmental Samples. Rebeca López-serna, Sandra Perez, Mira Petrovic*, Damià Barceló
, 2012
, Pages 337-353
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 4 Primary, Secondary and Tertiary Amines and their Isosteres. D. K. Walker, R. M. Jones, A. N. R. Nedderman, P. A. Wright
, 2010
, Pages 168-209
- Human Stem Cell Toxicology, Chapter 6 Current Developments in the Use of Human Stem Cell Derived Cardiomyocytes to Examine Drug-induced Cardiotoxicity. Varun Ahuja, Sharad Sharma, Raj Kamboj
, 2016
, Pages 124-159
- UHPLC in Life Sciences, Subject Index
, 2012
, Pages 429-447
- Quantitative In Silico Chromatography: Computational Modelling of Molecular Interactions, Appendix
, 2014
, Pages 278-326
- Pharmaceuticals in the Environment, Distribution of Pharmaceutical Residues in the Environment. Benoit Roig, Vince D’Aco
, 2016
, Pages 34-69